CURRENT PRINT ISSUE
Volume 8 Issue 3
Subscriber Services>>
Welcome, Guest Log in Endocrine Today
BlogsnewswireRSSMobileVideoPodcastsNews on the GoGet CME
Search
Advanced SearchAdvanced search
  • Diabetes and Metabolism
    • Type 1 diabetes
    • Type 2 diabetes
    • Gestational diabetes
    • Hyperglycemia and hypoglycemia
    • Glycemic control
    • Diabetic therapeutic agents
    • Obesity and bariatric surgery
    • Cross-cultural care
    • Diabetic comorbidities
    • Patient management
  • Pediatric Endocrinology
    • Type 1 diabetes
    • Hyperglycemia and hypoglycemia
    • Growth hormone therapy
    • Diabetic therapeutic agents
    • Obesity
    • Cross-cultural care
    • Diabetic comorbidities
    • Gender identity disorders
  • Thyroid
    • Thyroid cancer
    • Thyroid-stimulating hormone
    • Hypothyroidism
    • Hyperthyroidism
    • Thyroid nodules
    • Parathyroid
    • Thyrogenous scanning
  • Cardiometabolic Disorders
    • Cardiovascular disease
    • Hypertension and hypotension
    • Metabolic syndrome
    • Myocardial infarction
    • Atherosclerosis
    • Hyperlipidemia
    • Stroke
    • Coronary heart disease
  • Hormone Therapy
    • Hormone replacement therapy
    • Estrogen therapy
    • Testosterone therapy
    • Growth hormone therapy
    • Anabolic steroid abuse
    • Gender identity disorders
    • Menopause
  • Bone and Mineral Metabolism
    • Osteoporosis and fractures
    • Osteonecrosis of the jaw
    • Bone mineral density
    • Calcium and vitamin D supplementation
  • Neuroendocrinology
    • Idiopathic short stature
    • Pituitary
    • IGF-I levels
  • Adrenal
    • HPA axis
    • Noncongenital adrenal hyperplasia
    • Congenital adrenal hyperplasia
    • Pheochromocytoma
  • Reproduction and Androgen Disorders
    • PCOS
    • Hyperandrogenism
    • Androgen deficiency
    • Menopause
    • Cross-cultural care
  • Features
  • Meeting Highlights
  • In the Journals
  • Meet the Editorial Board
  • Resource Center:
    Type 2 Diabetes
    Michael Kleerekoper, MD, MACE HbA1c assay for type 2 diabetes: use and considerations

    In its annual update to the Standards of Care, the American Diabetes Association (ADA) endorsed the HbA1c assay as one of four recommended diagnostic tests to diagnose and screen for diabetes.
    Click here

Meeting Highlights
Renal Week 2009

Risks outweighed benefits of darbepoetin alfa in patients with type 2 diabetes, CKD, anemia

December 01, 2009

Olmesartan medoxomil delayed microalbuminuria in patients with type 2 diabetes

November 04, 2009

More from Renal Week 2009
  • RECENT MEETINGS

American Heart Association Scientific Sessions 2009

The Obesity Society 27th Annual Scientific Meeting

20th World Diabetes Congress

American Society for Reproductive Medicine 65th Annual Meeting

20th Annual North American Menopause Society Annual Meeting
more meetings 
 

Register Login Contact Us Help Advertising Information About Us Supporters Links
Privacy Policy
Copyright © 2010 SLACK, Inc. All Rights Reserved.